Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects

Addiction Biology

Volumn 8, Issue 1, 2003, Pages 23-32

  Gerra, Gilberto ^a   Zaimovic, A ^a   Moi, G ^a   Bussandri, M ^a   Delsignore, R ^b   Caccavari, R ^a   Brambilla, F ^a  

^a AUSL   (Italy)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CLONIDINE; DOPAMINE RECEPTOR; GROWTH HORMONE; PLACEBO; PROLACTIN; SEROTONIN RECEPTOR;

ABSTINENCE; ADULT; ARTICLE; BRAIN MAPPING; CLINICAL ARTICLE; COMORBIDITY; DETOXIFICATION; DRUG ABUSE; GENETIC VARIABILITY; HEROIN DEPENDENCE; HUMAN; HYDROCORTISONE RELEASE; MALE; NEUROENDOCRINE SYSTEM; NEUROTRANSMITTER RELEASE; NORADRENALIN RELEASE; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; PSYCHOPATHY; SUBSTANCE ABUSE;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANTISOCIAL PERSONALITY DISORDER; BRAIN; BROMOCRIPTINE; CASE-CONTROL STUDIES; CLONIDINE; DOPAMINE; DOPAMINE AGONISTS; FENFLURAMINE; HEROIN DEPENDENCE; HUMANS; MALE; NEUROSECRETORY SYSTEMS; NOREPINEPHRINE; SEROTONIN; SEROTONIN AGENTS;

EID: 0037360275     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/1355621031000069846     Document Type: Article

References (61)

1. Miller L. Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style. J Subst Abuse Treat 1991;8:277-91.
2. Tarter RE, Laird S, Bukstein O. Multivariate comparison of adolescent offspring of substance abuse parents: community and treatment samples. J Subst Abuse 1991;3:301-6.
3. Kofoed L, MacMillan J. Alcoholism and antisocial personality. The sociobiology of an addiction. J Nerv Ment Dis 1986;174:332-5.
4. Collins JJ, Schlenger WE, Jordan BK. Antisocial personality and substance abuse disorders. Bull Am Acad Psychiatry Law 1988;16:187-98.
5. Moffitt TE, Caspi A. Annotation: implications of violence between intimate partners for child psychologists and psychiatrists. J Child Psychol Psychiatry 1998;39:137-44.
6. Murdoch D, Pihl RO, Ross D. Alcohol and crimes of violence: present issues. Int J Addict 1990;25:1065-81.
7. Dawkins MP. Drug use and violent crime among adolescents. Adolescence 1997;32:395-405.
8. Kellam S, Ialongo N, Brown H, et al. Attention problems in first grade and shy and aggressive behaviours as antecedents to later heavy or inhibited substance use. NIDA Res Monogr 1989;95:368-9.
9. Kellam SG, Brown CH, Fleming JP. Social adaptation to first grade and teenage drug, alcohol and cigarette use. J Sch Health 1982;52:301-6.
10. Kellam SG, Ensminger ME, Simon MB. Mental health in first grade and teenage drug, alcohol, and cigarette use. Drug Alcohol Depend 1980;5:273-304.
11. Kellam SG, Stevenson DL, Rubin BR. How specific are the early predictors of teenage drug use?. NIDA Res Monogr 1983;43:329-34.
12. Darke S, Hall W, Swift W. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug Alcohol Depend 1994;34:253-7.
13. Kelly TH, Cherek DR. The effects of alcohol on free-operant aggressive behaviour. J Stud Alcohol Suppl 1993;11:40-52.
14. Hallikainen T, Saito T, Lachman HM, et al. Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behaviour. Mol Psychiatry 1999;4:385-8.
15. Parsian A. Sequences analysis of exon 8 of MAO-A gene in alcoholics with antisocial personality and normal controls. Genomies 1999;55:290-5.
16. Virkkunen M, Goldman D, Linnoila M. Serotonin in alcoholic violent offenders. Ciba Found Symp 1996;194:168-77.
17. Allen TJ, Moeller FG, Rhoades HM, Cherek DR. Subjects with a history of drug dependence are more aggressive than subjects with no drug use history. Drug Alcohol Depend 1997;46:95-103.
18. Gerra G, Caccavari R, Fontanesi B, et al. Alpha-2-adrenoreceptors sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder. Neuropsychobiology 1994;30:15-19.
19. Virkkunen M, Linnoila M. Serotonin in early-onset alcoholism. Recent Dev Alcohol 1997;13:173-89.
20. Kuikka JT, Tiihonen J, Bergstrom KA, Karhu J, Rasanen P, Eronen M. Abnormal structure of human striatal dopamine re-uptake sites in habitually violent alcoholic offenders: a fractal analysis. Neurosci Lett 1998;253:195-7.
21. Tiihonen J, Kuikka JT, Bergstrom KA, et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur J Nucl Med 1997;24:1253-60.
22. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview according to DSM-III-R. Washington DC: American Psychiatric Press, 1990.
23. Fava M, Guaraldi GB, Mazzi F, Rigatelli M. Intervista Clinica Strutturata per il DSM-III-R. Florence: Organizzazioni Speciali, 1993.
24. Pfohl B, Blum N, Zimmerman M, Stangl D. Structured interview for personality disorders, revised version. Iowa City, IA: University of Iowa, 1989.
25. Hathaway SR, McKinley JC. Minnesota multifasic personality inventory-2. Manual. Minneapolis: University of Minnesota, 1989.
26. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957;21:343-9.
27. Castrogiovanni P, Maremmani I, Di Muro A. Aggressive behaviour and hostility in depression: clinical aspects. In: Placidi GF, Dell'Osso L, Nisticò G, Akiskal HS, editors. Recurrent mood disorders. Berlin Heidelberg: Springer-Verlag, 1993, pp. 51-65.
28. Wechsler CD. Manual for the Wechsler adult intelligence scale. New York: Psychological Corporation, 1955.
29. Wechsler CD. WAIS-R manual. New York: Psychological Corporation, 1985.
30. Reitan RM, Wolfson D. Conventional intelligence measurements and neuropsychological concepts of adaptive abilities. J Clin Psychol 1992;48:521-9.
31. Kalia M. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons. Brain Res 1991;548:111-25.
32. Schmidt CJ, Black CK, Taylor VL. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxy-methamphetamine, p-chloroamphetamine or methamphetamine to rats. Eur J Pharmacol 1991;203:41-9.
33. Zaczek R, Battaglia G, Culp S, Appel NM, Contrera JF, De Souza EB. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. J Pharmacol Exp Ther 1990;253:104-12.
34. Brambilla F, Carito M, Zanoboni A, Colla SG, Muller EE. Lisuride-induced stimulation of growth hormone release and inhibition of prolactin secretion in heroin-addicted subjects and controls. Neuroendocrinol Lett 1988;10:393-8.
35. Maccario M, Procopio M, Grottoli S, et al. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism 1996;45:342-6.
36. Cusimano G, Capriani C, Bonifati V, Meco G. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients. Acta Neurol Scand 1991;83:145-50.
37. Muller EE, Locatelli V, Ghigo E, et al. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications. Drugs 1991;41:161-77.
38. Ayalon D, Persitz E, Ravid R, et al. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome. Clin Endocrinol (Oxf) 1979;11:201-15.
39. Wang GJ, Volkow ND, Fowler JS, et al. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 1997;16:174-82.
40. Comings DE, Gade R, Wu S, et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviours. Mol Psychiat 1997;32:44-56.
41. Berrettini WH, Persico AM. Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans. Biol Psychiat 1996;40:144-7.
42. Hill SY, Zezza N, Wipprecht G, Xu J, Neiswanger K. Linkage studies of D2 and D4 receptor genes and alcoholism. Am J Med Genet 1999;88:676-85.
43. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 1994;34:175-80.
44. Blum K, Braverman ER, Holder JM, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviours. J Psychoact Drugs 2000;32(Suppl:i-iv):1-112.
45. Caine SB, Negus SS, Mello NK, et al. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 2002;22:2977-88.
46. Matsushita S, Muramatsu T, Murayama M, Nakane J, Higuchi S. Alcoholism, ALDH2*2 allele and the A1 allele of the dopamine D2 receptor gene: an association study. Psychiatry Res 2001;104:19-26.
47. Gerra G, Caccavari R, Marcato A, et al. Alpha-1 and -2 adrenoceptor subsensitivity in siblings of opioid addicts with personality disorders and depression. Acta Psychiatr Scand 1994;90:269-73.
48. Shekim WO, Dekirmenjian H, Chapel JL, Javaid J, Davis JM. Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys. J Pediatr 1979;95:389-94.
49. Rogeness GA, Hernandez JM, Macedo CA, Mitchell EL. Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry 1982;139:307-11.
50. Rogeness GA, Hernandez JM, Macedo CA, Amrung SA, Hoppe SK. Near-zero plasma dopamine-beta-hydroxylase and conduct disorder in emotionally disturbed boys. J Am Acad Child Psychiatry 1986;25:521-7.
51. Brambilla F, Lampertico M, Panerai AE, Sali L, Salerno F, Muller EE. Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers. Psychiatry Res 1984;13:295-304.
52. Coccaro EF, Lawrence T, Trestman R, Gabriel S, Klar HM, Siever LJ. Growth hormone responses to intravenous clonidine challenge correlate with behavioural irritability in psychiatric patients and healthy volunteers. Psychiatry Res 1991;39:129-39.
53. Zuckerman M. The psychobiological model for impulsive unsocialized sensation seeking: a comparative approach. Neuropsychobiology 1996;34:125-9.
54. Vanyukov MM, Moss HB, Yu LM, Deka R. A dinucleotide repeat polymorphism at the gene for monoamine oxidase A and measures of aggressiveness. Psychiatry Res 1995;59:35-41.
55. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. Association between catechol O-methyl-transferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 1998;155:835-7.
56. Linnoila M, Virkkunen M, Roy A. Biochemical aspects of aggression in man. Clin Neuropharmacol 1986;9:377-9.
57. Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behaviour. Arch Gen Psychiat 1989;46:587-99.
58. Roy A, Virkkunen M, Guthrie S, Linnoila M. Indices of serotonin and glucose metabolism in violent offenders, arsonists, and alcoholics. Ann NY Acad Sci 1986;487:202-20.
59. Gerra G, Zaimovic A, Timpano M, et al. Neuroendocrine correlates of temperament traits in abstinent opiate addicts. J Subst Abuse 2000;11:337-54.
60. Tan EC, Yeo BK, Ho BK, Tay AH, Tan CH. Evidence for an association between heroin dependence and a VNTR polymorphism at the serotonin transporter locus. Mol Psychiat 1999;4:215-17.
61. Schmidt LG, Dufeu P, Heinz A, Kuhn S, Rommelspacher H. Serotonergic dysfunction in addiction: effects of alcohol, cigarette smoking and heroin on platelet 5-HT content. Psychiatry Res 1997;72:177-85.